Skip Nav Destination
Issues
Blood Purification 2010, Vol. 29, No. 2
Special Section
Title Page / Table of Contents
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 75–78.
https://doi.org/10.1159/000275826
Preface
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 79–80.
https://doi.org/10.1159/000259723
Paper
Water for Haemodialysis and Related Therapies: Recent Standards and Emerging Issues
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 81–85.
https://doi.org/10.1159/000249212
The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 86–92.
https://doi.org/10.1159/000245630
Special Considerations for Antihypertensive Agents in Dialysis Patients
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 93–98.
https://doi.org/10.1159/000245631
The Potential Role of Plasma Gelsolin in Dialysis-Related Protein-Energy Wasting
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 99–101.
https://doi.org/10.1159/000245632
How to Successfully Achieve Salt Restriction in Dialysis Patients? What Are the Outcomes?
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 102–104.
https://doi.org/10.1159/000245633
Haemodialysis-Induced Myocardial Stunning in Chronic Kidney Disease – A New Aspect of Cardiovascular Disease
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 105–110.
https://doi.org/10.1159/000245634
Immune Mechanisms Involved in Cardiovascular Complications of Chronic Kidney Disease
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 114–120.
https://doi.org/10.1159/000245636
An Approach to Addressing Depression in Patients with Chronic Kidney Disease
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 121–124.
https://doi.org/10.1159/000245637
Ethnicity and Renal Replacement Therapy
Topic Article Package:
Topic Article Package: Diabetes
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 125–129.
https://doi.org/10.1159/000245638
The Gut: The Forgotten Organ in Uremia?
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 130–136.
https://doi.org/10.1159/000245639
Phosphate Elimination in Modalities of Hemodialysis and Peritoneal Dialysis
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 137–144.
https://doi.org/10.1159/000245640
Peritonitis – Does Peritoneal Dialysis Modality Make a Difference?
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 145–149.
https://doi.org/10.1159/000245641
Reverse Epidemiology, Obesity and Mortality in Chronic Kidney Disease: Modelling Mortality Expectations Using Energetics
Topic Article Package:
Topic Article Package: Diabetes
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 150–157.
https://doi.org/10.1159/000245642
Endothelial Progenitor Cells and Endothelial Vesicles – What Is the Significance for Patients with Chronic Kidney Disease?
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 158–162.
https://doi.org/10.1159/000245643
Calcium Balance in Dialysis Is Best Managed by Adjusting Dialysate Calcium Guided by Kinetic Modeling of the Interrelationship between Calcium Intake, Dose of Vitamin D Analogues and the Dialysate Calcium Concentration
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 163–176.
https://doi.org/10.1159/000245924
The Role of Peripheral Ultrafiltration in the Management of Acute Decompensated Heart Failure
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 177–182.
https://doi.org/10.1159/000245644
A Selective Cytopheretic Inhibitory Device to Treat the Immunological Dysregulation of Acute and Chronic Renal Failure
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 183–190.
https://doi.org/10.1159/000245645
Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Critically Ill
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 191–196.
https://doi.org/10.1159/000245646
A Mathematical Model of Regional Citrate Anticoagulation in Hemodialysis
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 197–203.
https://doi.org/10.1159/000245647
Automated Regional Citrate Anticoagulation: Technological Barriers and Possible Solutions
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 204–209.
https://doi.org/10.1159/000245648
Modeling Hepatitis C Virus Therapies Combining Drugs and Lectin Affinity Plasmapheresis
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 210–215.
https://doi.org/10.1159/000245649
Novel Insights into the Pathobiology of the Vascular Access – Do They Translate into Improved Care?
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 216–229.
https://doi.org/10.1159/000245650
Further Section
Abstracts
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 230–242.
https://doi.org/10.1159/000245925
Author Index Vol. 29, No. 2, 2010
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 243.
https://doi.org/10.1159/000275828
Subject Index Vol. 29, No. 2, 2010
Subject Area:
Nephrology
Blood Purif (2010) 29 (2): 244.
https://doi.org/10.1159/000275829
